High-intensity adopters had reduction in documentation for full postadoption periods and following learning period
Weight-Loss Drug Zepbound Now in Single-Dose Vials at Half the Price
By Ernie Mundell HealthDay ReporterTUESDAY, Aug. 27, 2024 (HealthDay News) — Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication …
After Weighting, 3.6 Million Likely to Be Newly Eligible for Semaglutide
If all newly eligible beneficiaries receive semaglutide, maximum Medicare spending could be $34 to $145 billion annually
Awareness of Unruptured Aneurysm Diagnosis Increases Risk for Mental Illness
Incidence rate of mental illness higher among those with UIA, especially in younger age groups
Prevalence of HTN Increases With Neighborhood Disadvantage
Higher hypertension rate and lower treatment rate seen for highest versus lowest ADI quintile neighborhood
Women Have Lower Risk for Postoperative A-Fib After Cardiac Surgery
Men and women with poAF have higher risk for death than those without poAF, with higher risk seen for women than men
Exposure to Tobacco on TV, Streaming Varies by Sociodemographics
Disparities in exposure seen by race or ethnicity, education level, and smoking status
Study Reveals Heart Failure Risks in American Indian Communities
Older age, smoking, macroalbuminuria, microalbuminuria, previous MI, diabetes, and glycated hemoglobin predict risk
CMR-Modeled PCWP Independent Risk Factor for Heart Failure
Characteristics associated with elevated CMR-modeled PCWP include hypertension, BMI, age, male sex, alcohol consumption
Mitral Valve Surgery Linked to Lower Rates of Adverse Outcomes in AFMR
Surgery associated with significantly lower rate of heart failure hospitalization, all-cause mortality despite more severe disease status